Skip to main content

and
  1. No Access

    Article

    Heterozygous mutations in the straitjacket region of the latency-associated peptide domain of TGFB2 cause Camurati–Engelmann disease type II

    Camurati–Engelmann disease (CED) is an autosomal dominant bone dysplasia characterized by progressive hyperostosis of the skull base and diaphyses of the long bones. CED is further divided into two subtypes, C...

    Zheng Wang, Mitsuhiro Kometani, Leonid Zeitlin, Yael Wilnai in Journal of Human Genetics (2024)

  2. Article

    Open Access

    Prediction and causal inference of cardiovascular and cerebrovascular diseases based on lifestyle questionnaires

    Cardiovascular and cerebrovascular diseases (CCVD) are prominent mortality causes in Japan, necessitating effective preventative measures, early diagnosis, and treatment to mitigate their impact. A diagnostic ...

    Riku Nambo, Shigehiro Karashima, Ren Mizoguchi, Seigo Konishi in Scientific Reports (2024)

  3. Article

    Open Access

    A clinical assessment of portable point-of-care testing for quick cortisol assay during adrenal vein sampling

    This study assessed the clinical performance of point-of-care testing (POCT) for quick cortisol assay (QCA) during adrenal vein sampling (AVS) using a newly invented portable quantitative assay instrument. An ...

    Ko Aiga, Mitsuhiro Kometani, Shigehiro Karashima, Seigo Konishi in Scientific Reports (2023)

  4. No Access

    Article

    In vivo relationship between bound and free insulin in patients with diabetes having anti-insulin antibodies

    The Scatchard plot of anti-insulin antibodies is curvilinear, indicating heterogeneity in binding sites. However, the relationship between bound insulin (B) and free insulin (F) in patients with anti-insulin anti...

    Hiroyuki Asaka, Shigehiro Karashima, Daisuke Chujo in Diabetology International (2023)

  5. No Access

    Article

    Impact of gut microbiome on the renin-aldosterone system: Shika-machi Super Preventive Health Examination results

    The renin-angiotensin-aldosterone system (RAAS) is a regulatory mechanism of the endocrine system and is associated with various diseases, including hypertension and renal and cardiovascular diseases. The gut ...

    Ren Mizoguchi, Shigehiro Karashima, Yuna Miyajima, Kohei Ogura in Hypertension Research (2023)

  6. Article

    Open Access

    A hyperaldosteronism subtypes predictive model using ensemble learning

    This study aimed to develop a machine-learning algorithm to diagnose aldosterone-producing adenoma (APA) for predicting APA probabilities. A retrospective cross-sectional analysis of the Japan Rare/Intractable...

    Shigehiro Karashima, Masaki Kawakami, Hidetaka Nambo in Scientific Reports (2023)

  7. Article

    Open Access

    Safety and feasibility of radiofrequency ablation using bipolar electrodes for aldosterone-producing adenoma: a multicentric prospective clinical study

    Evaluation of feasibility and safety of percutaneous radiofrequency ablation using bipolar radiofrequency devices in a prospective multicenter cohort of patients with benign aldosterone-producing adenoma. A to...

    Sota Oguro, Ryo Morimoto, Kazumasa Seiji, Hideki Ota, Tomo Kinoshita in Scientific Reports (2022)

  8. Article

    Open Access

    Artificial Intelligence in Current Diabetes Management and Prediction

    Artificial intelligence (AI) can make advanced inferences based on a large amount of data. The mainstream technologies of the AI boom in 2021 are machine learning (ML) and deep learning, which have made signif...

    Akihiro Nomura, Masahiro Noguchi, Mitsuhiro Kometani in Current Diabetes Reports (2021)

  9. Article

    Open Access

    Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study

    Plasma aldosterone-to-renin ratio (ARR) is popularly used for screening primary aldosteronism (PA). Some medications, including diuretics, are known to have an effect on ARR and cause false-negative and false-...

    Toshitaka Sawamura, Shigehiro Karashima, Satoshi Nagase in BMC Endocrine Disorders (2020)

  10. No Access

    Article

    Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice

    It has been suggested that aldosterone breakthrough during treatment with a type 1 angiotensin II receptor (AT1R) blocker (ARB) may be an important risk factor for the progression of renal and cardiovascular d...

    Atsushi Hashimoto, Yoshimichi Takeda, Shigehiro Karashima in Hypertension Research (2020)

  11. No Access

    Article

    Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling

    The primary aldosteronism (PA) subtype is usually confirmed by CT and adrenal venous sampling (AVS). However, the subtype diagnosis by AVS is not necessarily consistent with the subtype diagnosis by CT. Patien...

    Daisuke Aono, Mitsuhiro Kometani, Shigehiro Karashima in Hypertension Research (2019)

  12. Article

    Open Access

    Study Protocol for the Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on Glycemic Control in Patients with Type 2 Diabetes Mellitus

    Nutritional intervention is effective in improving glycemic control in patients with type 2 diabetes but requires large inputs of manpower. Recent improvements in photo analysis technology facilitated by artif...

    Rie Oka, Akihiro Nomura, Ayaka Yasugi, Mitsuhiro Kometani, Yuko Gondoh in Diabetes Therapy (2019)

  13. Article

    Open Access

    C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study

    Despite the widespread use of glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1ras) to improve glycemic regulation, with a low risk of hypoglycemia and weight reduction, their effectiveness varies among...

    Azusa Ohbatake, Kunimasa Yagi, Shigehiro Karashima, Yuki Shima in Diabetes Therapy (2019)

  14. Article

    Open Access

    Cortisol overproduction results from DNA methylation of CYP11B1 in hypercortisolemia

    Adrenocortical hormone excess, due to primary aldosteronism (PA) or hypercortisolemia, causes hypertension and cardiovascular complications. In PA, hypomethylation of aldosterone synthase (CYP11B2) is associated ...

    Mitsuhiro Kometani, Takashi Yoneda, Masashi Demura, Hiroshi Koide in Scientific Reports (2017)

  15. Article

    Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism

    The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by ep...

    Shigehiro Karashima, Takashi Yoneda, Mitsuhiro Kometani in Hypertension Research (2016)